InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,735.60
(
0.07%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
82.94
(
-0.32%
)
Bitcoin
61,790.43
(
-1.77%
)
Post# of 251813
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: ghmm post# 204601

Monday, 09/26/2016 5:12:17 PM

Monday, September 26, 2016 5:12:17 PM

Post# of 251813
GLPG / GILD:

The company said they couldn't comment on P3 trial till Gilead goes ahead... and then these appear today

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis
https://clinicaltrials.gov/ct2/show/NCT02914522

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
https://clinicaltrials.gov/ct2/show/NCT02914535

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
https://clinicaltrials.gov/ct2/show/NCT02914561

Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
https://clinicaltrials.gov/ct2/show/NCT02914600
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up